Search clinical trials for: HDARAC
Total 249 results
-
University of ArkansasUniversity of IowaNot yet recruitingPlasma Cell Disorder
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingParkinson DiseaseUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaCanada, United States, Czechia, Israel, Italy, Korea, Republic of, Brazil, United Kingdom, Japan, Taiwan, Australia, Poland, Spain, France, Russian Federation, Sweden, Ukraine, Greece
-
Navy General Hospital, BeijingRecruitingPrimary Central Nervous System LymphomaChina
-
Navy General Hospital, BeijingRecruitingPrimary Central Nervous System LymphomaChina
-
Kutahya Health Sciences UniversityRecruitingPain | Knee Osteoarthritis | Physical DisabilityTurkey
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
Wake Forest University Health SciencesCompleted
-
Washington State UniversityUniversity of WashingtonActive, not recruitingAlcohol Use DisorderUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)TerminatedSoft Tissue Sarcoma | Renal Cell Carcinoma | Metastatic DiseaseUnited States
-
Janssen Pharmaceutical K.K.Completed
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingNewly Diagnosed Multiple Myeloma
-
Shahid Sadoughi University of Medical Sciences...CompletedDyspepsia | Peptic Ulcer | H-pyloriIran, Islamic Republic of
-
General Hospital of Chinese Armed Police ForcesCompletedCoronary Artery DiseaseChina
-
dr hab. n. med. Agnieszka WierzbowskaCopernicus Memorial Hospital; Polish Adult Leukemia GroupUnknownAcute Myeloid LeukemiaPoland
-
Hospices Civils de LyonCompletedAcute Myeloid LeukemiaFrance
-
Washington University School of MedicineJanssen, LPWithdrawn
-
Wake Forest UniversityCompletedActinic KeratosisUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
Technische Universität DresdenPfizer; Novartis PharmaceuticalsRecruiting
-
NCIC Clinical Trials GroupS*BIOCompleted
-
Chong Kun Dang PharmaceuticalUnknownHuntington DiseaseKorea, Republic of
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingCervical Cancer | Human Immunodeficiency Virus | Human Papillomavirus | CIN2 | CIN3South Africa
-
The Netherlands Cancer InstituteUnknownMelanoma | Skin NeoplasmsNetherlands
-
Nordic Lymphoma GroupAmgenCompletedDiffuse Large B-Cell LymphomaNorway, Denmark, Finland, Sweden
-
Laboratorios Leti, S.L.Completed
-
Actavis Inc.CompletedActinic KeratosisUnited States
-
Spear PharmaceuticalsCompleted
-
Yale UniversityMerck Sharp & Dohme LLCCompletedNon-Small Cell Lung Cancer (NSCLC)United States
-
Acute Leukemia French AssociationVersailles HospitalCompleted
-
NYU Langone HealthTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | MyelofibrosesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsTerminatedNon-Hodgkin's LymphomaUnited States
-
Grupo de Estudos Multicentricos em Onco-HematologiaUnknownMultiple Myeloma Stage IBrazil
-
Yale UniversityMerck Sharp & Dohme LLCCompletedAdvanced Breast CancerUnited States
-
Copenhagen University Hospital at HerlevUnknownPolycythemia Vera | Essential ThrombocythemiaSweden, United Kingdom, Denmark, Netherlands
-
Thomas Jefferson UniversityJanssen Scientific Affairs, LLCActive, not recruitingPlasma Cell MyelomaUnited States
-
Huashan HospitalCompleted
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Massachusetts General HospitalMerck Sharp & Dohme LLC; Dana-Farber Cancer Institute; Brigham and Women's HospitalTerminatedPancreatic Cancer | Adenocarcinoma of the PancreasUnited States
-
Institute of Hematology & Blood Diseases HospitalUnknown
-
Emory UniversityUniversity of Pittsburgh; Hematology/Oncology Pharmacy AssociationRecruitingMalignant Digestive System NeoplasmUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompletedCombined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerAnal CancerUnited States
-
Rockefeller UniversityAarhus University Hospital; University Hospital of CologneCompletedHuman Immunodeficiency Virus (HIV)Germany, Denmark, United States
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Genentech, Inc.CompletedHead and Neck Cancer | Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Brain Stem Neoplasm | Pineal Region Neoplasm | Recurrent Visual Pathway Glioma | Refractory Visual Pathway GliomaUnited States
-
NCIC Clinical Trials GroupS*BIOCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Cooperative Study Group A for HematologyUnknownAcute Myeloid LeukemiaKorea, Republic of